Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: Psoriatic Arthritis

Biologics in psoriasis: can they prevent joint involvement?

Presented By
Ms Kathleen Miao, Keck School of Medicine of USC, CA, USA
Conference
AAD 2023

15 May, 2023 12:46

Bimekizumab: Robust 1-year results in treating psoriatic arthritis

Presented By
Prof. Christopher Ritchlin, University of Rochester Medical Center, USA
Trial
Phase 3
Conference
ACR 2022

1 December, 2022 14:33

Selective IL-23 inhibitor achieves long-term disease control in many patients with active PsA

Presented By
Dr Kim Papp, Probity Medical Research, Canada
Trial
KEEPsAKE 1; KEEPsAKE 2
Conference
EADV 2022

5 November, 2022 10:28

AI machine learning algorithm useful in early detection of PsA

Presented By
Dr Jonathan Shapiro, Maccabi Healthcare Services, Israel
Conference
EADV 2022

5 November, 2022 10:24

How to treat enthesitis in 2022

Presented By
Prof. Dennis McGonagle, University of Leeds, United Kingdom
Trial
Phase 3, SEAM-PsA, EXCEED, SPIRIT-H2H
Conference
EULAR 2022

21 July, 2022 17:42

Baseline cardiovascular risk linked to higher rates of MACE in PsA and PsO patients receiving tofacitinib

Presented By
Prof. Lars Erik Kristensen , Copenhagen University Hospital, Denmark
Conference
EULAR 2022

21 July, 2022 17:30

Treat-to-target dose reduction effective in spondyloarthritis

Presented By
Dr Celia Michielsens , Sint Maartenskliniek, the Netherlands
Conference
EULAR 2022

21 July, 2022 17:21

Many RA and PsA patients have problems with their sex life

Presented By
Dr Carlos Valera-Ribera , Doctor Peset University Hospital, Spain
Conference
EULAR 2022

21 July, 2022 17:12

Psoriatic arthritis: significant improvement with bimekizumab

Presented By
Prof. Iain McInnes , Glasgow University, United Kingdom
Trial
Phase 3, BE OPTIMAL
Conference
EULAR 2022

21 July, 2022 14:36

EULAR 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EULAR 2022

22 June, 2022 23:51

New insights into psoriasis comorbidity

Presented By
Prof. Joel Gelfand, University of Pennsylvania, USA
Conference
AAD 2022

17 May, 2022 12:12

Explaining arthropathy development through IL-4 and IL-13 blockade

Presented By
Dr Charlie Bridgewood, University of Leeds, UK
Conference
PFGC 2021

3 February, 2022 10:51

Patients on immunomodulators need 2 COVID-19 vaccinations before seroconversion

Presented By
Dr Ali Al-Janabi, University of Manchester, UK
Conference
PFGC 2021

2 February, 2022 15:22

Selective IL-23 inhibition normalises gene expression in active PsA

Presented By
Ms Michelle Miron
Trial
Phase 3, DISCOVER-1&-2
Conference
PFGC 2021

2 February, 2022 13:48

Selective IL-23 inhibition: a new option in active PsA

Presented By
Prof. Andrew Östör, Monash University, Australia
Trial
Phase 3, KEEPsAKE 1, KEEPsAKE 2
Conference
ACR 2021

14 January, 2022 10:52

Ustekinumab: highly efficacious in PSA independent of methotrexate

Presented By
Dr Michaela Köhm, Goethe-University Frankfurt, Germany
Conference
ACR 2021

14 January, 2022 10:48

B-cell depleting medication increases COVID-19 breakthrough infection outcome risk

Presented By
Prof. Jean Liew, Boston University, MA, USA
Conference
ACR 2021

14 January, 2022 10:45

PFGC 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
PFGC 2021

22 December, 2021 08:12

ACR 2021 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
ACR 2021

22 November, 2021 16:18

Existing and upcoming small molecules in psoriasis

Presented By
Dr Enikö Sonkoly , Karolinska University Hospital, Sweden
Trial
POETYK PSO; PSOARING
Conference
EADV 2021

18 November, 2021 13:19

Ixekizumab shows sustained improvements in pain and fatigue at 3 years

Presented By
Prof. Ana-Maria Orbai, Johns Hopkins University School of Medicine, USA
Trial
SPIRIT-P2
Conference
EULAR 2020

14 August, 2020 14:15

Adalimumab added to methotrexate yields better results in PsA than methotrexate escalatio

Presented By
Dr Laura Coates, Oxford University, United Kingdom
Trial
Phase 4, CONTROL
Conference
EULAR 2020

14 August, 2020 14:09

Upadacitinib provides fast onset of improvement in psoriatic arthritis

Presented By
Prof. Iain McInnes, University of Glasgow, Scotland
Trial
SELECT-PsA-1
Conference
EULAR 2020

14 August, 2020 14:02

Secukinumab monotherapy as efficient as adalimumab

Presented By
Prof. Iain McInnes, University of Glasgow, United Kingdom
Trial
Phase 3, EXCEED
Conference
EULAR 2020

14 August, 2020 13:11

ECLIPSE trial: skin clearance independent of PsA status at baseline

Presented By
Prof. Kristian Reich
Trial
Phase 3, ECLIPSE
Conference
AAD 2020

7 August, 2020 13:12

Few serious infections in offspring with exposure to non-TNFi biologics or tofacitinib

Presented By
Dr Evelyne Vinet, McGill University, Montreal, Canada
Conference
ACR 2019

4 February, 2020 23:12

Psoriasis onset determines sequence of symptoms

Presented By
Prof. Umut Kalyoncu, Hacettepe University, Turkey
Conference
ACR 2019

4 February, 2020 23:07

Higher psychiatric comorbidity in women with PsA

Presented By
Prof. Mehmet Duruöz, Marmara University Hospital, Turkey
Conference
ACR 2019

4 February, 2020 22:50

Selective IL-23 blocker shows remarkable efficacy in patients with psoriatic arthritis

Presented By
Prof. Atul Deodhar, Oregon Health & Science University, USA
Trial
Phase 3, DISCOVER
Conference
ACR 2019

4 February, 2020 19:53

CARDAS study shows increased prevalence of cardiac valvular disorders in AS patients

Presented By
Mr Milad Baniaamam, Amsterdam University Medical Center, the Netherlands
Trial
CARDAS
Conference
ACR 2019

4 February, 2020 10:04

Efficacy and safety of ixekizumab versus adalimumab in patients with PsA

Presented By
Dr Roy Fleischmann, University of Texas Southwestern Medical Center, Dallas, USA
Conference
EULAR 2019

4 September, 2019 11:20

Efficacy and safety of bimekizumab in patients with active PsA

Presented By
Dr Christopher Ritchlin, University of Rochester Medical Centre, USA
Trial
Phase 2, BE ACTIVE
Conference
EULAR 2019

4 September, 2019 11:10

Filgotinib is efficacious and safe in PsA

Presented By
Prof. Philip Mease, Swedish Medical Center and University of Washington, Seattle, USA
Trial
Phase 2, EQUATOR
Conference
EULAR 2019

4 September, 2019 11:00

Ixekizumab improves signs and symptoms in TNFi-naïve PsA patients

Presented By
Dr Amanda Gellett, Eli Lilly, USA
Trial
Phase 3, SPIRIT-P2
Conference
EULAR 2019

4 September, 2019 10:50

Etanercept and methotrexate as first-line treatment in PsA

Presented By
Prof. Philip Mease, University of Washington, USA
Trial
Phase 3, SEAM-PsA
Conference
EULAR 2019

4 September, 2019 10:40

Unacceptable pain is common in patients with psoriatic arthritis

Presented By
Dr Tor Olofsson, Lund University, Sweden
Conference
EULAR 2019

4 September, 2019 10:33

NSAIDs consumption is linked to patient-assessed disease activity and decreases with use of TNF inhibitors

Presented By
Dr Olafur Palsson, University Hospital Reykjavik, Iceland
Trial
ICEBIO database
Conference
EULAR 2019

4 September, 2019 10:11

Advances in target-oriented therapy: psoriatic arthritis

Presented By
Prof. Wolf-Henning Boehncke, University of Geneva, Switzerland
Trial
ECLIPSA, TICOPA
Conference
SPIN 2019

21 June, 2019 23:48

Small molecules, apremilast, and TYK2

Presented By
Prof. Richard Langley, Dalhousie University, Canada
Trial
ESTEEM, PALACE, LIBERATE
Conference
SPIN 2019

21 June, 2019 09:45

IBD risk of treatment with IL-17 antagonists

Presented By
Dr Wolfgang Eigner, Medical University of Vienna, Austria
Conference
ECCO 2019

9 May, 2019 14:37

Plaque psoriasis – Efficacy of guselkumab

Trial
Phase 3, VOYAGE 1, VOYAGE 2
Conference
AAD 2019

19 April, 2019 20:06

Psoriasis and Biologics: The Beat Goes On

Presented By
Prof. Mark Lebwohl, Mount Sinai School of Medicine, USA
Conference
AAD 2019

19 April, 2019 14:06

Switching to biosimilar bDMARDs is safe and efficacious

Presented By
Prof. Kvien, University of Oslo and Diakonhjemmet Hospital, Norway
Trial
Phase 4, NOR-SWITCH
Conference
EULAR 2018

24 August, 2018 22:46
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy